Don't leave, TurboMice™ is coming to you!
Connecting to server... 0%
  • 4-Week Delivery: World’s fastest custom mouse model development.
  • TurboMice™ Tech: Proprietary high-efficiency gene-editing platform.
  • Full Capabilities: Expert conditional knockouts, knock-ins, and humanized models.
  • Validated Quality: Guaranteed high precision and model viability.
Partners' Projects

Ccl19 CreERT2 Mouse Model

Category Tag
Strain Name

Ccl19 CreERT2 Mouse Model (M02113)

Editing Type

Knockin

Gene Name

Ccl19 (mouse C-C motif chemokine ligand 19)

Gene Synonyms

ELC / CKb11 / MIP3B / Gm2023 / Scya19 / exodus-3

Strain Background

C57BL/6N

NCBI No.

Gene ID: 24047 / MGI:1346316

1. Fibroblastic reticular cell-specific gene function research Combined with Floxed mouse strains, time- and cell type-specific gene knockout or activation is achieved in Ccl19-positive fibroblastic reticular cells, supporting study of the key roles these stromal cells play in the structural formation, maintenance, and immune response regulation of secondary lymphoid organs such as lymph nodes, spleen, and Peyer’s patches.

2. Lymphocyte homing and immune response regulation Through lineage tracing, the dynamic changes and functions of Ccl19+ stromal cells and their descendants are studied during immune organ development, homeostasis, and inflammatory or tumor states. The functional mechanisms by which Ccl19+ stromal cells regulate the migration, localization, and interactions of immune cells such as T cells and dendritic cells through the secretion of chemokines (such as CCL19 and CCL21) and cytokines are also explored.

3. Tumor immunology and immunotherapy The regulatory effects of Ccl19+ stromal cells in lymphoid tissues such as tumor-draining lymph nodes on antitumor immune responses are studied, and their potential as new targets for immunotherapy is evaluated.

This mouse strain carries the CreERT2 fusion gene knocked into the chemokine Ccl19 locus, so that CreERT2 expression is driven by the endogenous Ccl19 promoter/enhancer. Ccl19 is specifically expressed in a subset of fibroblastic reticular cells within secondary lymphoid organs such as lymph nodes and splenic white pulp. These cells form the reticular scaffold of the T cell zone and secrete the chemokines CCL19 and CCL21, which are crucial for lymphocyte homing and the spatial organization of immune responses. The model allows conditional gene editing or lineage tracing in Ccl19-positive cells and their progeny at defined time points via tamoxifen induction, enabling dynamic and refined in vivo study of the development and function of lymphoid organ stromal cells and of their roles in immune responses, tumor immunity, and autoimmune diseases.

  1. Inducible rather than constitutive. CreERT2 remains cytoplasmic until tamoxifen is administered, so the timing of recombination is set by the investigator rather than by the developmental clock.
  2. Native locus control. The knock-in places CreERT2 at the endogenous Ccl19 locus, so expression follows the gene’s own promoter and enhancer instead of a borrowed promoter fragment.
  3. A defined stromal compartment. Recombination is confined to Ccl19-positive fibroblastic reticular cells of secondary lymphoid organs — the scaffold of the T cell zone — rather than to lymphoid tissue as a whole.
  4. Lineage tracing through progeny. Crossed to a LoxP reporter, the line marks Ccl19+ FRCs and their descendants, so the fate of the scaffold can be followed across development, homeostasis, and inflammation.
  5. One background, several immune contexts. Because these cells secrete CCL19 and CCL21 and organize lymphocyte homing and dendritic cell positioning, the same line supports work on lymphoid organ architecture, tumor-draining lymph node responses, and autoimmune disease.

FAQ

Game-changing benefits?

While competitors highlight germline efficiency gains, shorter timelines and enhanced 3Rs animal welfare benefits for their technologies, these are merely incremental improvements over traditional approaches. In sharp contrast, our proprietary technology delivers fully pure, homogeneous lineages—every single cell of the mice is derived exclusively from totipotent ES cells, with guaranteed 100% germline transmission efficiency. To experience these unparalleled benefits firsthand, enquire about your custom mouse model project with us or order embryos for in-house validation at your facility.

•Free initial design proposal with zero obligations.​
•Request a free quote!

All model generation projects of Mingceler operate under a fee-for-service framework.
IP Ownership: All intellectual property rights related to custom mouse models, including derived organs, tissues, cells, and biological materials, are the sole and exclusive property of the Client.
Third-Party Transfer Permission: The Client may independently decide to retain, utilize, or commercialize their custom models project materials (e.g., targeting vectors, ES cells, mouse lines) without the need for prior consent from Mingceler.
Licensing Exemption: The Client has full autonomy over all uses of the custom models or their derivatives, including but not limited to commercialization, distribution to third parties, and publication involving model data. No written license from Mingceler is required for such uses.

This website uses cookies

We use cookies to personalize content, provide social media features, and analyze our traffic. We also share information about your use of our site with our analytics partners. You can change your preferences at any time. For more information, please see our Privacy Policy Cookie Policy